This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Stammers, A. H Articles by Duncan, K. F Search for Related Content PubMed PubMed Citation Articles by Stammers, A. H Articles by Duncan, K. F Social Bookmarking                         What's this?

Pre-operative coagulopathy management of a neonate with complex congenital heart disease: a case study

Division of Clinical Perfusion Education, University of Nebraska Medical Center, Omaha, Nebraska

Eric D Rauch

Division of Clinical Perfusion Education, University of Nebraska Medical Center, Omaha, Nebraska

Lynne D Willett

Department of Neonatology, University of Nebraska Medical Center, Omaha, Nebraska

Jamie W Newberry

Division of Clinical Perfusion Education, University of Nebraska Medical Center, Omaha, Nebraska

Kim F Duncan

Department of Pediatric Cardiac Surgery, University of Nebraska Medical Center, Omaha, Nebraska

Severe coagulation defects often develop in neonates undergoing cardiac surgery, both as a result of the surgical intervention, and as pre-existing defects in the hemostatic mechanisms. The following case report describes a newborn patient with complex congenital heart disease and respiratory failure whose pre-operative coagulopathy was aggressively managed prior to surgical correction.

A 5-day-old, 2.5 kg child presented with interrupted aortic arch, ventricular septal defect, atrial septal defect, and patent ductus arteriosus. On admission, he was in respiratory arrest suffering from profound acidemia. In addition, the child was hypothermic (30.1°C), septic (Streptococcus viridans), and coagulopathic (disseminated intravascular coagulation - DIC). The patient was immediately intubated and initial coagulation assessment revealed the following: prothrombin time (PT) 48.9 s (international normalized ratio (INR) 15.7), activated partial thromboplastin time (aPTT) •106 s, platelet count 30 000 mm³, fibrinogen 15 mg dL^-1 and antithrombin III (AT-III) 10%.

Before cardiac surgery could be performed, the patient’s DIC was corrected with the administration of cryoprecipitate (15 ml), fresh frozen plasma (300 ml), and platelets (195 ml). In spite of the large transfusion of fresh frozen plasma, the AT-III activity, measured as a percentage, remained depressed at 33. Initial thromboelastographic (TEG) determination revealed an index of +2.02, and following 100 IU administration of an AT-III concentrate, declined to -2.32. Sequential TEG profiles were performed over several days, with the results used to guide both transfusion and medical therapy. The congenital heart defect correction was subsequently performed with satisfactory initial results, but the patient developed a fungal infection and expired on the 16th post-operative day.

The present case describes techniques of coagulation management for a newborn with both a severe hemostatic defect and congenital heart disease.

Perfusion, Vol. 15, No. 2, 161-168 (2000)
DOI: 10.1177/026765910001500212


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. P. Eaton Antifibrinolytic Therapy in Surgery for Congenital Heart Disease Anesth. Analg., April 1, 2008; 106(4): 1087 - 1100. [Abstract] [Full Text] [PDF]